Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study - Concepedia

Concepedia

Publication | Open Access

Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study

DOI Full Paper Access

28

Citations

18

References

2020

Year

Sam E. Mansour, Daniel F. Kiernan, Daniel B. Roth, David Eichenbaum, Nancy M. Holekamp, Samer E. Kaba, Erica Werts

British Journal of Ophthalmology

Abstract

NCT02424019.

References

	Year	Citations

Page 1